VIATRIS INC (VTRS) Fundamental Analysis & Valuation

NASDAQ:VTRS • US92556V1061

14.16 USD
-0.37 (-2.55%)
At close: Mar 6, 2026
14.1617 USD
+0 (+0.01%)
After Hours: 3/6/2026, 8:00:02 PM

This VTRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall VTRS gets a fundamental rating of 4 out of 10. We evaluated VTRS against 193 industry peers in the Pharmaceuticals industry. VTRS has a medium profitability rating, but doesn't score so well on its financial health evaluation. VTRS is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. VTRS Profitability Analysis

1.1 Basic Checks

  • VTRS had positive earnings in the past year.
  • VTRS had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VTRS reported negative net income in multiple years.
  • Each year in the past 5 years VTRS had a positive operating cash flow.
VTRS Yearly Net Income VS EBIT VS OCF VS FCFVTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • VTRS has a Return On Assets of -9.45%. This is in the better half of the industry: VTRS outperforms 68.91% of its industry peers.
  • VTRS has a better Return On Equity (-23.89%) than 66.32% of its industry peers.
  • The Return On Invested Capital of VTRS (3.44%) is better than 81.35% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for VTRS is significantly below the industry average of 13.08%.
Industry RankSector Rank
ROA -9.45%
ROE -23.89%
ROIC 3.44%
ROA(3y)-3.62%
ROA(5y)-1.8%
ROE(3y)-9.01%
ROE(5y)-4.67%
ROIC(3y)3.51%
ROIC(5y)3.8%
VTRS Yearly ROA, ROE, ROICVTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • Looking at the Operating Margin, with a value of 9.17%, VTRS belongs to the top of the industry, outperforming 81.87% of the companies in the same industry.
  • In the last couple of years the Operating Margin of VTRS has declined.
  • The Gross Margin of VTRS (39.55%) is better than 62.18% of its industry peers.
  • In the last couple of years the Gross Margin of VTRS has remained more or less at the same level.
Industry RankSector Rank
OM 9.17%
PM (TTM) N/A
GM 39.55%
OM growth 3Y-18.61%
OM growth 5Y-5.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y0.79%
VTRS Yearly Profit, Operating, Gross MarginsVTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

3

2. VTRS Health Analysis

2.1 Basic Checks

  • VTRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • VTRS has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VTRS has less shares outstanding
  • The debt/assets ratio for VTRS is higher compared to a year ago.
VTRS Yearly Shares OutstandingVTRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
VTRS Yearly Total Debt VS Total AssetsVTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • VTRS has an Altman-Z score of 1.01. This is a bad value and indicates that VTRS is not financially healthy and even has some risk of bankruptcy.
  • VTRS has a Altman-Z score (1.01) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of VTRS is 7.79, which is on the high side as it means it would take VTRS, 7.79 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 7.79, VTRS belongs to the best of the industry, outperforming 81.35% of the companies in the same industry.
  • VTRS has a Debt/Equity ratio of 0.85. This is a neutral value indicating VTRS is somewhat dependend on debt financing.
  • VTRS has a Debt to Equity ratio of 0.85. This is in the lower half of the industry: VTRS underperforms 68.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 7.79
Altman-Z 1.01
ROIC/WACC0.42
WACC8.2%
VTRS Yearly LT Debt VS Equity VS FCFVTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • VTRS has a Current Ratio of 1.38. This is a normal value and indicates that VTRS is financially healthy and should not expect problems in meeting its short term obligations.
  • VTRS's Current ratio of 1.38 is on the low side compared to the rest of the industry. VTRS is outperformed by 72.54% of its industry peers.
  • VTRS has a Quick Ratio of 1.38. This is a bad value and indicates that VTRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VTRS has a Quick ratio of 0.82. This is in the lower half of the industry: VTRS underperforms 79.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.82
VTRS Yearly Current Assets VS Current LiabilitesVTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

3

3. VTRS Growth Analysis

3.1 Past

  • VTRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.94%.
  • The earnings per share for VTRS have been decreasing by -11.71% on average. This is quite bad
  • Looking at the last year, VTRS shows a decrease in Revenue. The Revenue has decreased by -2.98% in the last year.
  • Measured over the past years, VTRS shows a small growth in Revenue. The Revenue has been growing by 3.66% on average per year.
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-4.2%
Revenue growth 5Y3.66%
Sales Q2Q%4.97%

3.2 Future

  • VTRS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.43% yearly.
  • The Revenue is expected to grow by 3.87% on average over the next years.
EPS Next Y6.3%
EPS Next 2Y8.73%
EPS Next 3Y12.45%
EPS Next 5Y16.43%
Revenue Next Year2.59%
Revenue Next 2Y2.23%
Revenue Next 3Y2.24%
Revenue Next 5Y3.87%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VTRS Yearly Revenue VS EstimatesVTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VTRS Yearly EPS VS EstimatesVTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

8

4. VTRS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 6.00, which indicates a rather cheap valuation of VTRS.
  • 94.30% of the companies in the same industry are more expensive than VTRS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of VTRS to the average of the S&P500 Index (26.29), we can say VTRS is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 5.64, the valuation of VTRS can be described as very cheap.
  • 94.82% of the companies in the same industry are more expensive than VTRS, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of VTRS to the average of the S&P500 Index (24.60), we can say VTRS is valued rather cheaply.
Industry RankSector Rank
PE 6
Fwd PE 5.64
VTRS Price Earnings VS Forward Price EarningsVTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • VTRS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VTRS is cheaper than 93.26% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of VTRS indicates a rather cheap valuation: VTRS is cheaper than 92.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.81
EV/EBITDA 7.1
VTRS Per share dataVTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as VTRS's earnings are expected to grow with 12.45% in the coming years.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y8.73%
EPS Next 3Y12.45%

5

5. VTRS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.67%, VTRS has a reasonable but not impressive dividend return.
  • VTRS's Dividend Yield is rather good when compared to the industry average which is at 0.70. VTRS pays more dividend than 95.85% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, VTRS pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

  • VTRS has paid a dividend for at least 10 years, which is a reliable track record.
  • VTRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
VTRS Yearly Dividends per shareVTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • VTRS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-15.97%
EPS Next 2Y8.73%
EPS Next 3Y12.45%
VTRS Yearly Income VS Free CF VS DividendVTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

VTRS Fundamentals: All Metrics, Ratios and Statistics

VIATRIS INC

NASDAQ:VTRS (3/6/2026, 8:00:02 PM)

After market: 14.1617 +0 (+0.01%)

14.16

-0.37 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners87.39%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change19.04%
Market Cap16.30B
Revenue(TTM)14.30B
Net Income(TTM)-3.51B
Analysts76.67
Price Target14.17 (0.07%)
Short Float %2.31%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP-15.97%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-09
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.32%
Min EPS beat(2)4.82%
Max EPS beat(2)5.83%
EPS beat(4)4
Avg EPS beat(4)5.04%
Min EPS beat(4)0.14%
Max EPS beat(4)9.36%
EPS beat(8)5
Avg EPS beat(8)2.36%
EPS beat(12)8
Avg EPS beat(12)2.58%
EPS beat(16)11
Avg EPS beat(16)2.43%
Revenue beat(2)2
Avg Revenue beat(2)2.47%
Min Revenue beat(2)2.14%
Max Revenue beat(2)2.79%
Revenue beat(4)3
Avg Revenue beat(4)1.21%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)2.79%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)3
Avg Revenue beat(12)-1.29%
Revenue beat(16)3
Avg Revenue beat(16)-1.86%
PT rev (1m)5.83%
PT rev (3m)14.42%
EPS NQ rev (1m)-7.16%
EPS NQ rev (3m)-10.04%
EPS NY rev (1m)-0.81%
EPS NY rev (3m)-0.51%
Revenue NQ rev (1m)1.07%
Revenue NQ rev (3m)1.07%
Revenue NY rev (1m)1.27%
Revenue NY rev (3m)1.41%
Valuation
Industry RankSector Rank
PE 6
Fwd PE 5.64
P/S 1.14
P/FCF 8.81
P/OCF 7.04
P/B 1.11
P/tB N/A
EV/EBITDA 7.1
EPS(TTM)2.36
EY16.67%
EPS(NY)2.51
Fwd EY17.72%
FCF(TTM)1.61
FCFY11.35%
OCF(TTM)2.01
OCFY14.2%
SpS12.42
BVpS12.78
TBVpS-6.21
PEG (NY)0.95
PEG (5Y)N/A
Graham Number26.05
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -23.89%
ROCE 4.36%
ROIC 3.44%
ROICexc 3.61%
ROICexgc 15.21%
OM 9.17%
PM (TTM) N/A
GM 39.55%
FCFM 12.94%
ROA(3y)-3.62%
ROA(5y)-1.8%
ROE(3y)-9.01%
ROE(5y)-4.67%
ROIC(3y)3.51%
ROIC(5y)3.8%
ROICexc(3y)3.63%
ROICexc(5y)3.92%
ROICexgc(3y)14.75%
ROICexgc(5y)18.05%
ROCE(3y)4.44%
ROCE(5y)4.84%
ROICexgc growth 3Y-14.75%
ROICexgc growth 5Y3.75%
ROICexc growth 3Y-11.49%
ROICexc growth 5Y9.86%
OM growth 3Y-18.61%
OM growth 5Y-5.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 7.79
Debt/EBITDA 3.04
Cap/Depr 16.62%
Cap/Sales 3.25%
Interest Coverage 2.66
Cash Conversion 56.35%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.82
Altman-Z 1.01
F-Score5
WACC8.2%
ROIC/WACC0.42
Cap/Depr(3y)15.31%
Cap/Depr(5y)14.37%
Cap/Sales(3y)2.89%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.94%
EPS 3Y-11.02%
EPS 5Y-11.71%
EPS Q2Q%5.56%
EPS Next Y6.3%
EPS Next 2Y8.73%
EPS Next 3Y12.45%
EPS Next 5Y16.43%
Revenue 1Y (TTM)-2.98%
Revenue growth 3Y-4.2%
Revenue growth 5Y3.66%
Sales Q2Q%4.97%
Revenue Next Year2.59%
Revenue Next 2Y2.23%
Revenue Next 3Y2.24%
Revenue Next 5Y3.87%
EBIT growth 1Y-26.08%
EBIT growth 3Y-22.03%
EBIT growth 5Y-2.16%
EBIT Next Year14.48%
EBIT Next 3Y9.13%
EBIT Next 5Y9.64%
FCF growth 1Y-5.38%
FCF growth 3Y-9.65%
FCF growth 5Y27.44%
OCF growth 1Y0.56%
OCF growth 3Y-7.78%
OCF growth 5Y13.46%

VIATRIS INC / VTRS FAQ

What is the ChartMill fundamental rating of VIATRIS INC (VTRS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to VTRS.


What is the valuation status for VTRS stock?

ChartMill assigns a valuation rating of 8 / 10 to VIATRIS INC (VTRS). This can be considered as Undervalued.


What is the profitability of VTRS stock?

VIATRIS INC (VTRS) has a profitability rating of 5 / 10.


What is the valuation of VIATRIS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for VIATRIS INC (VTRS) is 6 and the Price/Book (PB) ratio is 1.11.


How sustainable is the dividend of VIATRIS INC (VTRS) stock?

The dividend rating of VIATRIS INC (VTRS) is 5 / 10 and the dividend payout ratio is -15.97%.